Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, sold shares to cover tax obligations arising from vesting of restricted share units.
Summary
- On February 28, 2024, Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, disposed of 52 shares of common stock at a price of $126.36 to satisfy tax obligations.
- Additionally, 57 shares were disposed of at the same price for the same reason.
- Following these transactions, Deppe directly owns 34,930 shares of Quest Diagnostics common stock.
- Deppe also indirectly owns 682 shares through the company's 401(k) plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction to cover tax obligations. It doesn't indicate any significant positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders buy or sell their company's stock. It provides transparency into the transactions of individuals with access to non-public information.
Stakeholder Impact
- The stock sale has a minimal impact on shareholders as it is a small transaction by an individual executive.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock sale transactions. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.